Advisory Research Inc Harmony Biosciences Holdings, Inc. Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 17, 2022
SELL
$33.54 - $52.15 $8,049 - $12,516
-240 Reduced 0.55%
43,430 $2.12 Million
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $414,250 - $639,125
12,500 Added 40.1%
43,670 $2.12 Million
Q4 2021

Feb 11, 2022
SELL
$34.09 - $43.91 $3 Million - $3.86 Million
-87,880 Reduced 73.82%
31,170 $1.33 Million
Q3 2021

Nov 12, 2021
BUY
$25.68 - $38.61 $3.06 Million - $4.6 Million
119,050 New
119,050 $4.56 Million

Others Institutions Holding HRMY

# of Institutions
243
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email